SARS‐CoV‐2 targets neurons of 3D human brain organoids
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, organoids can be cultivated over months and probably even years, thus enabling the investigation of tissue maturation in a disease context as shown for SARS-CoV-2 infections in brain organoids87”
From Human disease models in drug development (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SARS-CoV-2 tropism for neurons87 and cortical astrocytes88 or its preference for mature cell types and distinct neurotoxic effects were demonstrated in brain organoids.”
From Human disease models in drug development (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 7×
“ACE-2 is an entry receptor for SARS-CoV and efficient replication of SARS-CoV (SARS outbreak in the year 2003) and also depends on the expression level of ACE-2 (Li et al , 2003; Hoffmann et al , 2020).”
InfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“We adapted previously described protocol to differentiate iPSCs into brain organoids described earlier (Lancaster et al , 2013; Gabriel et al , 2016).”
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“However, emerging case reports showed that patients infected with SARS-CoV-2 suffered a sudden and complete loss of the olfactory function, stroke, and other severe neurological symptoms (Chen et al , 2020; Helms et al , 2020; Poyiadji et al , 2020; Sedaghat & Karimi, 2020; Virani et al , 2020).”
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 1×
“Cortical neurons are positioned basally to the VZ, forming a cortical plate ) (Lancaster & Knoblich, 2014; Giandomenico & Lancaster, 2017; Gopalakrishnan, 2019).”
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Research works printed but not linked: 1
- Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press
Cited by
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Song, E., Zhang, C., Israelow, B., Lu-Culligan, A., Prado, A. V., Skriabine, S., Lu, P., Weizman, O.-E., Liu, F., Dai, Y., et al. (2020) · doi:10.1101/2020.06.25.169946 · Cited by 1,064
Dysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620
Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.001 · Cited by 552
de Melo, G. D., Lazarini, F., Levallois, S., Hautefort, C., Michel, V., Larrous, F., Verillaud, B., Aparicio, C., Wagner, S., Gheusi, G., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8396 · Cited by 500
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
“395,396 403 – 406 SARS-CoV-2 infection of neural tissues leads to increased tau hyperphosphorylation, a hallmark of Alzheimer ’ s disease, suggesting that SARS-CoV-2 infection may have long-term neurological effects that could contribute to the onset of neurodegeneration.”
BackgroundJacob, F., Pather, S. R., Huang, W.-K., Zhang, F., Wong, S. Z. H., Zhou, H., Cubitt, B., Fan, W., Chen, C. Z., Xu, M., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.016 · Cited by 438
Katsura, H., Sontake, V., Tata, A., Kobayashi, Y., Edwards, C. E., Heaton, B. E., Konkimalla, A., Asakura, T., Mikami, Y., Fritch, E. J., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.005 · Cited by 416
COVID-19 and the Chemical Senses: Supporting Players Take Center Stage
Cooper, K. W., Brann, D. H., Farruggia, M. C., Bhutani, S., Pellegrino, R., Tsukahara, T., Weinreb, C., Joseph, P. V., Larson, E. D., Parma, V., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.032 · Cited by 340
Morphological, cellular and molecular basis of brain infection in COVID-19 patients
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão-Teles, C., da Silva Zuccoli, G., Reis-de-Oliveira, G., Silva-Costa, L. C., et al. (2020) · doi:10.1101/2020.10.09.20207464 · Cited by 331
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Human cerebral organoids — a new tool for clinical neurology research
Eichmüller, O. L., & Knoblich, J. A. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00723-9 · Cited by 297
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
Kumari, P., Rothan, H. A., Natekar, J. P., Stone, S., Pathak, H., Strate, P. G., Arora, K., Brinton, M. A., & Kumar, M. (2021) · Viruses · doi:10.3390/v13010132 · Cited by 295
“Human iPSC derived neural progenitors cells (NPCs) have been shown to be permissive to SARS-CoV-2 infection and both viral proteins and infectious viral particle production were detected in neurospheres and brain organoids infected with SARS-CoV-2 [18,19].”
BackgroundZhang, L., Zhou, L., Bao, L., Liu, J., Zhu, H., Lv, Q., Liu, R., Chen, W., Tong, W., Wei, Q., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00719-9 · Cited by 294
“who showed that SARS-CoV-2 preferably targeted neurons of brain organoids.(5) Likewise, Jacob et al.”
BackgroundResultInfluentialThree-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2
Youk, J., Kim, T., Evans, K. V., Jeong, Y.-I., Hur, Y., Hong, S. P., Kim, J. H., Yi, K., Kim, S. Y., Na, K. J., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.004 · Cited by 266
Trougakos, I. P., Stamatelopoulos, K., Terpos, E., Tsitsilonis, O. E., Aivalioti, E., Paraskevis, D., Kastritis, E., Pavlakis, G. N., & Dimopoulos, M. A. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00703-5 · Cited by 278
“In support SARSCoV-2 can directly target neurons of 3D human brain organoids [50, 51] and the virus has been found in cerebrospinal fluid and neuronal cells [49, 52] indicating that SARS-CoV-2 is neuroinvasive, neurotropic and neurovirulent.”
BackgroundThe blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
Krasemann, S., Haferkamp, U., Pfefferle, S., Woo, M. S., Heinrich, F., Schweizer, M., Appelt-Menzel, A., Cubukova, A., Barenberg, J., Leu, J., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.12.011 · Cited by 229
Cognitive impact of COVID-19: looking beyond the short term
Miners, S., Kehoe, P. G., & Love, S. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 226
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
Wang, C., Zhang, M., Garcia, G., Tian, E., Cui, Q., Chen, X., Sun, G., Wang, J., Arumugaswami, V., & Shi, Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.12.018 · Cited by 223
The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
Bauer, L., Laksono, B. M., de Vrij, F. M. S., Kushner, S. A., Harschnitz, O., & van Riel, D. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.02.006 · Cited by 217
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
Synowiec, A., Szczepański, A., Barreto-Duran, E., Lie, L. K., & Pyrc, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 212
Cerebral dysfunctions caused by sepsis during ageing
Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
Prelli Bozzo, C., Nchioua, R., Volcic, M., Koepke, L., Krüger, J., Schütz, D., Heller, S., Stürzel, C. M., Kmiec, D., Conzelmann, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24817-y · Cited by 185
Sabate‐Soler, S., Nickels, S. L., Saraiva, C., Berger, E., Dubonyte, U., Barmpa, K., Lan, Y. J., Kouno, T., Jarazo, J., Robertson, G., et al. (2022) · Glia · doi:10.1002/glia.24167 · Cited by 183
Human brain organoids assemble functionally integrated bilateral optic vesicles
Gabriel, E., Albanna, W., Pasquini, G., Ramani, A., Josipovic, N., Mariappan, A., Schinzel, F., Karch, C. M., Bao, G., Gottardo, M., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.07.010 · Cited by 178
Self-citationThe role of Neuropilin-1 in COVID-19
Mayi, B. S., Leibowitz, J. A., Woods, A. T., Ammon, K. A., Liu, A. E., & Raja, A. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009153 · Cited by 178
“A recently published study suggests that there may be ACE2-independent pathways for SARS-CoV-2 entry and infection of neurons [41].”
BackgroundAnimal and translational models of SARS-CoV-2 infection and COVID-19
Johansen, M. D., Irving, A., Montagutelli, X., Tate, M. D., Rudloff, I., Nold, M. F., Hansbro, N. G., Kim, R. Y., Donovan, C., Liu, G., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00340-z · Cited by 173
Tropism of SARS-CoV-2 for human cortical astrocytes
Andrews, M. G., Mukhtar, T., Eze, U. C., Simoneau, C. R., Ross, J., Parikshak, N., Wang, S., Zhou, L., Koontz, M., Velmeshev, D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122236119 · Cited by 159
Application of 3D bioprinting in the prevention and the therapy for human diseases
Yi, H.-G., Kim, H., Kwon, J., Choi, Y.-J., Jang, J., & Cho, D.-W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00566-8 · Cited by 164
Wang, L., Sievert, D., Clark, A. E., Lee, S., Federman, H. G., Gastfriend, B. D., Shusta, E. V., Palecek, S. P., Carlin, A. F., & Gleeson, J. G. (2021) · Nature Medicine · doi:10.1038/s41591-021-01443-1 · Cited by 163
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharides, T. C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02696-0 · Cited by 166
Human organoid models to study SARS-CoV-2 infection
Han, Y., Yang, L., Lacko, L. A., & Chen, S. (2022) · Nature Methods · doi:10.1038/s41592-022-01453-y · Cited by 163
Amirifar, L., Shamloo, A., Nasiri, R., de Barros, N. R., Wang, Z. Z., Unluturk, B. D., Libanori, A., Ievglevskyi, O., Diltemiz, S. E., Sances, S., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121531 · Cited by 155
Modelling human brain development and disease with organoids
Birtele, M., Lancaster, M. A., & Quadrato, G. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00804-1 · Cited by 187
Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation
Semerdzhiev, S. A., Fakhree, M. A. A., Segers‐Nolten, I. M. J., Blum, C., & Claessens, M. M. A. E. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00666 · Cited by 156
Neurological complications and infection mechanism of SARS-CoV-2
Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 149
“In these brain organoids, viruses were observed to mainly infect mature cortical neurons, and neurodegenerative effects were also detected in SARS-CoV-2-infected cells, such as hyperphosphorylation, cell necrosis, and Tau protein mislocation.(207) Furthermore, these authors discovered no procreative virus replication…”
BackgroundMethodInfluentialTiwari, S. K., Wang, S., Smith, D. M., Carlin, A. F., & Rana, T. M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.005 · Cited by 142
“Several studies using stem cell-derived organoids have started to provide further insights into SARS-CoV-2 infection of various cell types and host responses, and the discovery of new drug candidates (Han et al., 2020; Jacob et al., 2020; Katsura et al., 2020; Lamers et al., 2020; Mykytyn et al., 2021; Pellegrini et a…”
CNS implications of COVID-19: a comprehensive review
Nagu, P., Parashar, A., Behl, T., & Mehta, V. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0070 · Cited by 145
Kong, W., Montaño, M., Corley, M. J., Helmy, E. W., Kobayashi, H., Kinisu, M., Suryawanshi, R. K., Luo, X., Royer, L. A., Roan, N. R., et al. (2022) · mBio · doi:10.1128/mbio.02308-22 · Cited by 135
Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models
Huang, Y., Huang, Z., Tang, Z., Chen, Y., Huang, M., Liu, H., Huang, W., Ye, Q., & Jia, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740574 · Cited by 152
SARS-CoV-2 Invades the Central Nervous System via the Olfactory Route in Rhesus Monkeys
Li, J., Yang, Y., Yu, W., Zhao, Y., Long, H., Gao, J., Ding, K., Ma, C., Li, J., Zhao, S., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00591-7 · Cited by 132
SARS-CoV-2 promotes microglial synapse elimination in human brain organoids
Samudyata, S., Oliveira, A. O., Malwade, S., de Sousa, N. R., Goparaju, S. K., Gracias, J., Orhan, F., Steponaviciute, L., Schalling, M., Sheridan, S. D., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01786-2 · Cited by 130
Fullard, J. F., Lee, H.-C., Voloudakis, G., Suo, S., Javidfar, B., Shao, Z., Peter, C. J., Zhang, W., Jiang, S., Corvelo, A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00933-8 · Cited by 111
“Studies employing neuronal organoids have provided conflicting results regarding the effect of SARSCoV-2 on neurons [9, 11, 12] or on epithelial cells in the choroid plexus [13, 14].”
ResultCan SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks, S. M., Rosas-Hernandez, H., Alejandro Ramirez-Lee, M., Cuevas, E., & Talpos, J. C. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.031 · Cited by 97
“, 2020) and published data showing that SARS-CoV-2 can infect organoid models of the human brain (Ramani et al., 2020).”
COVID-19 and psychosis risk: real or delusional concern?
Watson, C. J., Thomas, R. H., Solomon, T., Michael, B. D., Nicholson, T. R., & Pollak, T. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135491 · Cited by 103
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
Azar, J. H., Bahmad, H. F., Daher, D., Moubarak, M. M., Hadadeh, O., Monzer, A., Bitar, S. A., Jamal, M., Al‐Sayegh, M., & Abou-Kheir, W. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147667 · Cited by 110
Fumagalli, V., Ravà, M., Marotta, D., Lucia, P. D., Laura, C., Sala, E., Grillo, M., Bono, E. B., Giustini, L., Perucchini, C., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl9929 · Cited by 102
Wang, P., Jin, L., Zhang, M., Wu, Y., Duan, Z., Guo, Y., Wang, C., Guo, Y., Chen, W., Liao, Z., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01054-w · Cited by 125
Martínez-Mármol, R., Giordano-Santini, R., Kaulich, E., Cho, A.-N., Przybyla, M., Riyadh, M. A., Robinson, E., Chew, K. Y., Amor, R., Meunier, F. A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2248 · Cited by 94
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
Xu, G., Li, Y., Zhang, S., Peng, H., Wang, Y., Li, D., Jin, T., He, Z., Tong, Y., Qi, C., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00578-7 · Cited by 110
Käufer, C., Schreiber, C. S., Hartke, A.-S., Denden, I., Stanelle‐Bertram, S., Beck, S., Kouassi, N. M., Beythien, G., Becker, K., Schreiner, T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103999 · Cited by 98
Charnley, M., Islam, S., Bindra, G. K., Engwirda, J., Ratcliffe, J., Zhou, J., Mezzenga, R., Hulett, M. D., Han, K., Berryman, J. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30932-1 · Cited by 103
SARS-CoV-2 targets glial cells in human cortical organoids
McMahon, C. L., Staples, H. M., Gaži, M., Carrion, R., & Hsieh, J. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.01.016 · Cited by 98
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Silva, N. M. L. E., Barros‐Aragão, F. G. Q., Felice, F. G. D., & Ferreira, S. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109023 · Cited by 106
Neuroinflammation and Its Impact on the Pathogenesis of COVID-19
Almutairi, M. M., Sivandzade, F., Albekairi, T. H., Alqahtani, F., & Cucullo, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745789 · Cited by 103
“Another study demonstrated that SARS-CoV-2 infection induces axonal-somal Tau distribution and neuronal death (164).”
SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia
Mishra, R., & Banerjea, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656700 · Cited by 94
“org 10 neuronal damage similar to neurodegenerative phenotype (20).”
BackgroundInfluentialSuresh, S., Ankul Singh, S., Rushendran, R., Vellapandian, C., & Prajapati, B. G. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1303111 · Cited by 99
Advanced human developmental toxicity and teratogenicity assessment using human organoid models
Li, M., Gong, J., Gao, L., Zou, T., Kang, J., & Xu, H. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113429 · Cited by 84
The Promise and Potential of Brain Organoids
Smirnova, L., & Härtung, T. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302745 · Cited by 101
Liu, J., Tan, B., Wu, S., Gui, Y., Suo, J., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26570 · Cited by 87
Rosa, R. B., Dantas, W. M., do Nascimento, J. C. F., da Silva, M. V., de Oliveira, R. N., & Pena, L. (2021) · Viruses · doi:10.3390/v13030379 · Cited by 98
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Silva-Pedrosa, R., Salgado, A. J., & Ferreira, P. E. (2023) · Cells · doi:10.3390/cells12060930 · Cited by 84
Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
DeKosky, S. T., Kochanek, P. M., Valadka, A. B., Clark, R. S. B., Chou, S., Au, A. K., Horvat, C. M., Jha, R. M., Mannix, R., Wisniewski, S. R., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7332 · Cited by 92
“Other investigators have confirmed that SARS-CoV-2 targets neurons of three-dimensional human brain organoids.(155) Finally, it is important to remain vigilant to the potential for endogenous retroviruses to contribute to CNS disease.”
BackgroundSenolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
Aguado, J., Amarilla, A. A., Taherian Fard, A., Albornoz, E. A., Tyshkovskiy, A., Schwabenland, M., Chaggar, H. K., Modhiran, N., Gómez-Inclán, C., Javed, I., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00519-6 · Cited by 80
Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
Verkhratsky, A., Li, Q., Melino, S., Melino, G., & Shi, Y. (2020) · Biology Direct · doi:10.1186/s13062-020-00282-3 · Cited by 89
Post COVID-19 Condition in Children and Adolescents: An Emerging Problem
Izquierdo-Pujol, J., Morón‐López, S., Dalmau, J., González-Aumatell, A., Carreras‐Abad, C., Hernández, M. J. M., Rodrigo, C., & Martínez‐Picado, J. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.894204 · Cited by 95
“Although SARS-CoV-2 predominantly affects the respiratory tract, studies in human brain organoids have shown that SARS-CoV-2 can also infect neurons (49, 50).”
BackgroundImplications of SARS‐CoV‐2 infection for neurogastroenterology
Marasco, G., Lenti, M. V., Cremon, C., Barbaro, M. R., Stanghellini, V., Sabatino, A. D., & Barbara, G. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14104 · Cited by 81
Karuppan, M. K. M., Devadoss, D., Nair, M. G., Chand, H. S., & Lakshmana, M. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02245-1 · Cited by 86
Pentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
“tical neurons was significantly higher in 60-days than in 15days-old human brain organoids, suggesting that the virus prefers relatively mature neuronal cell types [231].”
SARS-CoV-2: is there neuroinvasion?
McQuaid, C., Brady, M., & Deane, R. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00267-y · Cited by 74
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
de Melo, G. D., Perraud, V., Alvarez, F., Prado, A. V., Kim, S., Kergoat, L., Coléon, A., Trüeb, B. S., Tichit, M., Piazza, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40228-7 · Cited by 82
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
Pacheco‐Herrero, M., Soto-Rojas, L. O., Harrington, C. R., Flores-Martinez, Y. M., Villegas-Rojas, M. M., León-Aguilar, A. M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Corniel-Taveras, C. N., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.660087 · Cited by 76
Duan, X., Tang, X., Nair, M. S., Zhang, T., Qiu, Y., Zhang, W., Wang, P., Huang, Y., Xiang, J., Wang, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109920 · Cited by 66
Neurotropic Viruses, Astrocytes, and COVID-19
Verdev, P. T., Potokar, M., Kolenc, M., Korva, M., Avšič‐Županc, T., Zorec, R., & Jorgačevski, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662578 · Cited by 77
Han, Y., Yuan, K., Wang, Z., Liu, W., Lu, Z.-A., Liu, L., Shi, L., Yan, W., Yuan, J., Li, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01629-8 · Cited by 74
“Furthermore, SARS-CoV-2 preferably targets cortical neurons of 3D human brain organoids, where it has altered Tau distribution, and phosphorylation, which increased expression of neurodegeneration genes and induced neuronal death, providing further insights into the neuropathogenesis of SARS-CoV-2 infection [108, 109].”
BackgroundChronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
Vidal, E., López-Figueroa, C., Rodon, J., Pérez, M., Brustolin, M., Cantero, G., Guallar, V., Izquierdo‐Useros, N., Carrillo, J., Blanco, J., et al. (2021) · Veterinary Pathology · doi:10.1177/03009858211066841 · Cited by 68
“Indeed, SARS-CoV-2-infected neurons express hACE2 in this model as demonstrated by in situ hybridization experiments(8,15) Also, studies performed in human brain organoids have demonstrated the neurotropism of SARS-CoV-2 despite a lower expression of the ACE2 receptor and TMPRSS2 when compared to lung epithelial cells…”
Choosing a cellular model to study SARS-CoV-2
de Souza, G. A. P., Bideau, M. L., Boschi, C., Wurtz, N., Colson, P., Aherfi, S., Devaux, C. A., & Scola, B. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1003608 · Cited by 78
“The results, however, have been conflicting, detecting the SARS-CoV-2 virus in the neurons but not producing infection (Ramani et al., 2020).”
ResultMesci, P., de Souza, J. S., Martin‐Sancho, L., Macia, Á., Saleh, A., Yin, X., Snethlage, C. E., Adams, J. W., Avansini, S. H., Herai, R. H., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001845 · Cited by 73
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
Föhse, K., Geckin, B., Zoodsma, M., Kılıç, G., Liu, Z., Röring, R. J., Overheul, G. J., van de Maat, J., Bulut, O. P., Hoogerwerf, J. J., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109762 · Cited by 68
Self-citationInfection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus
Yi, S. A., Nam, K. H., Yun, J., Gim, D., Joe, D., Kim, Y. H., Kim, H., Han, J., & Lee, J. (2020) · Viruses · doi:10.3390/v12091004 · Cited by 70
The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
Chen, F., Chen, Y., Wang, Y., Ke, Q., & Cui, L. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00316-y · Cited by 65
Shen, W., Elahi, M., Logue, J., Yang, P., Baracco, L., Reece, E. A., Wang, B., Li, L., Blanchard, T. G., Han, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.31.478476 · Cited by 64
Costas‐Carrera, A., Sánchez‐Rodríguez, M. M., Cañizares, S., Ojeda, A., Martín‐Villalba, I., Primé‐Tous, M., Rodríguez-Rey, A., Segú, X., Valdesoiro‐Pulido, F., Borràs, R., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100425 · Cited by 70
Trends and challenges in modeling glioma using 3D human brain organoids
Mariappan, A., Goranci-Buzhala, G., Ricci‐Vitiani, L., Pallini, R., & Gopalakrishnan, J. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00679-7 · Cited by 66
Self-citationHuman Brain Organoids as Models for Central Nervous System Viral Infection
Depla, J. A., Mulder, L., de Sá, R. V., Wartel, M., Sridhar, A., Evers, M. M., Wolthers, K. C., & Pajkrt, D. (2022) · Viruses · doi:10.3390/v14030634 · Cited by 63
Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection
Ferren, M., Favède, V., Décimo, D., Iampietro, M., Lieberman, N. A. P., Weickert, J., Pélissier, R., Mazelier, M., Terrier, O., Moscona, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26096-z · Cited by 65
Human 3D brain organoids: steering the demolecularization of brain and neurological diseases
Adlakha, Y. K. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01523-w · Cited by 69
Venkataraman, L., Fair, S. R., McElroy, C. A., Hester, M. E., & Fu, H. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10068-9 · Cited by 56
Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection
Dobrindt, K., Hoagland, D. A., Seah, C., Kassim, B. S., O’Shea, C. P., Murphy, A., Iskhakova, M., Fernando, M. B., Powell, S. K., Deans, P. J. M., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.010 · Cited by 57
“Likewise, RNA-sequencing data from hiPSC-derived neural progenitor cells (NPCs) (Hoffman et al., 2017), NGN2-induced glutamatergic neurons (Zhang et al., 2013), ASCL1/DLX2-induced GABAergic neurons (Yang et al., 2017), and ASCL1/NURR1/LMX1Ainduced dopaminergic neurons (Dobrindt et al., 2020), as well as differentiated…”
InfluentialKarnik, M., Beeraka, N. M., Uthaiah, C. A., Nataraj, S. M., Bettadapura, A. D. S., Aliev, G., & Madhunapantula, S. V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02399-6 · Cited by 57
Bodnar, B. H., Zhang, Y., Liu, J., Lin, Y., Wang, P., Wei, Z., Saribas, S., Zhu, Y., Li, F., Wang, X., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.682272 · Cited by 58
Amyloid processing in COVID‐19‐associated neurological syndromes
Ziff, O. J., Ashton, N. J., Mehta, P. R., Brown, R., Athauda, D., Heaney, J., Heslegrave, A. J., Benedet, A. L., Blennow, K., Checkley, A. M., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15585 · Cited by 54
“…infections Although it remains unclear whether SARS- CoV-2 infects neurons with studies reporting conflicting results (Matschke et al., 2020; Ramani et al., 2020)— expression of sAPPs in infected CNS microglia may serve as a restriction to protect against COVID-19 spread across the BBB…”
Menuchin-Lasowski, Y., Schreiber, A., Lecanda, A., Mecate‐Zambrano, A., Brunotte, L., Psathaki, O. E., Ludwig, S., Rauen, T., & Schöler, H. R. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.015 · Cited by 56
Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids
Ramani, A., Pranty-Weßelmann, A. I., & Gopalakrishnan, J. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.007 · Cited by 53
“SARS-CoV-2 cortical neuron d SARS-CoV-2 targets neurons in organoid d associates tau abnormalities and induces cell death (Ramani et al., 2020)”
InfluentialSelf-citationAmyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
Bhardwaj, T., Gadhave, K., Kapuganti, S. K., Kumar, P., Brotzakis, Z. F., Saumya, K. U., Nayak, N., Kumar, A., Joshi, R., Mukherjee, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36234-4 · Cited by 54
Porciúncula, L. O., Goto‐Silva, L., Ledur, P. F., & Rehen, S. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.674563 · Cited by 59
“Two-month-old organoids positive for SARS-CoV-2 exhibited an altered Tau localization pattern from axons to soma, Tau hyperphosphorylation, and apparent neuronal death (Ramani et al., 2020).”
BackgroundBrain organoid protocols and limitations
Zhao, H., & Haddad, G. G. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1351734 · Cited by 68
Applications of Brain Organoids for Infectious Diseases
Fan, W., Christian, K. M., Song, H., & Ming, G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167243 · Cited by 58
“In these brain organoids, neurons and glial cells were sparsely infected by SARS-CoV-2, probably due to the low expression of the viral receptor ACE2 in the cells.(8,83,84) Surprisingly, choroid plexus epithelial cells showed relatively high and productive infection by SARS-CoV-2 (Figure 2).”
de Melo, B. A. G., Benincasa, J. C., Cruz, E. M., Maricato, J. T., & Porcionatto, M. A. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.11.009 · Cited by 55
Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID‐19
Bodnar, B. H., Patel, K., Ho, W., Luo, J. J., & Hu, W. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26720 · Cited by 54
“Intriguingly, the neuronal apoptosis induced by SARS‐CoV‐2 infection appears dependent on Type II interferon response (IFNγ), but not Type I interferon response (IFNα/β).(20,58,63,64)”
InfluentialBauer, L., Rissmann, M., Benavides, F. F. W., Leijten, L. M. E., van Run, P., Begeman, L., Kroeze, E. J. B. V., Lendemeijer, B., Smeenk, H., de Vrij, F. M. S., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01426-4 · Cited by 56
Metadata
- Authors
- Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
- Affiliations
- Düsseldorf University Hospital (DE)
- Centre National de la Recherche Scientifique (FR)
- University of Cologne (DE)
- University Hospital Münster (DE)
- Corresponding author
- Schaal, Heiner
- Gopalakrishnan, Jay
- ORCID
- Ramani, Anand
- Müller, Lisa
- Ostermann, Philipp N
- Gabriel, Elke
- Müller‐Schiffmann, Andreas
- Mariappan, Aruljothi
- Goureau, Olivier
- Gruell, Henning
- Walker, Andreas
- Houwaart, Torsten
- Dilthey, Alexander
- Wohlgemuth, Kai
- Omran, Heymut
- Wieczorek, Dagmar
- Adams, Ortwin
- Timm, Jörg
- Korth, Carsten
- Schaal, Heiner
- Gopalakrishnan, Jay
- Venue
- The EMBO Journal
- Published
- 2020-09-23
- Volume
- 39
- Issue
- 20
- Pages
- e106230-e106230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7560208
- OpenAlex
- W3081536095
- Cited by
- 518
- References
- 63
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
- FWCI
- 42.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fritz Thyssen Stiftung (10.17.2.018MN)
- Juergen Manchot Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
- MeSH terms
- Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.